MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Zoetis Inc

Gesloten

SectorGezondheidszorg

159.56 -2.43

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

159.31

Max

166.05

Belangrijke statistieken

By Trading Economics

Inkomsten

-101M

581M

Verkoop

-83M

2.3B

K/W

Sectorgemiddelde

30.101

63.778

EPS

1.4

Dividendrendement

1.21

Winstmarge

25.076

Werknemers

13,800

EBITDA

-133M

906M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+27.04% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.21%

2.39%

Volgende Winsten

6 mei 2025

Volgende Ex Dividend datum

21 apr 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-5.1B

74B

Vorige openingsprijs

161.99

Vorige sluitingsprijs

159.56

Nieuwssentiment

By Acuity

29%

71%

87 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Zoetis Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 nov 2024, 12:47 UTC

Winsten

Zoetis Lifts Guidance On Strong Demand as 3Q Beats Market Views

6 aug 2024, 11:52 UTC

Winsten

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

20 feb 2025, 08:00 UTC

Top Nieuws

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

13 feb 2025, 13:47 UTC

Winsten

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

13 feb 2025, 12:09 UTC

Winsten

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

13 feb 2025, 12:08 UTC

Winsten

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

13 feb 2025, 12:08 UTC

Winsten

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

13 feb 2025, 12:00 UTC

Winsten

Zoetis 4Q EPS $1.29 >ZTS

13 feb 2025, 12:00 UTC

Winsten

Zoetis 4Q Rev $2.32B >ZTS

13 feb 2025, 12:00 UTC

Winsten

Zoetis 4Q Net $581M >ZTS

4 nov 2024, 14:05 UTC

Winsten

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips -- IBD

4 nov 2024, 12:06 UTC

Winsten

Zoetis Sees 2024 Rev $9.2B-$9.3B >ZTS

4 nov 2024, 12:06 UTC

Winsten

Zoetis Sees 2024 Adj EPS $5.86-Adj EPS $5.92 >ZTS

4 nov 2024, 12:05 UTC

Winsten

Zoetis 3Q Adj EPS $1.58 >ZTS

4 nov 2024, 12:00 UTC

Winsten

Zoetis 3Q Net $682M >ZTS

4 nov 2024, 12:00 UTC

Winsten

Zoetis 3Q EPS $1.50 >ZTS

4 nov 2024, 12:00 UTC

Winsten

Zoetis 3Q Rev $2.39B >ZTS

6 aug 2024, 11:44 UTC

Winsten

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6 aug 2024, 11:09 UTC

Winsten

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6 aug 2024, 11:08 UTC

Winsten

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6 aug 2024, 11:08 UTC

Winsten

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6 aug 2024, 11:08 UTC

Winsten

Zoetis 2Q Adj EPS $1.56 >ZTS

6 aug 2024, 11:00 UTC

Winsten

Zoetis 2Q Net $624M >ZTS

6 aug 2024, 11:00 UTC

Winsten

Zoetis 2Q Rev $2.36B >ZTS

6 aug 2024, 11:00 UTC

Winsten

Zoetis 2Q EPS $1.37 >ZTS

2 mei 2024, 17:43 UTC

Winsten

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 mei 2024, 13:06 UTC

Winsten

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 mei 2024, 11:27 UTC

Winsten

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2 mei 2024, 11:00 UTC

Winsten

Zoetis 1Q Net $599M >ZTS

2 mei 2024, 11:00 UTC

Winsten

Zoetis 1Q EPS $1.31 >ZTS

Peer Vergelijking

Prijswijziging

Zoetis Inc Prognose

Koersdoel

By TipRanks

27.04% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 207.71 USD  27.04%

Hoogste 242 USD

Laagste 180 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zoetis Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Technische score

By Trading Central

162.8401 / 165.48Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Strong Bearish Evidence

Sentiment

By Acuity

87 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.